Navigation Links
Focused Treatment For Childhood Cancer

A poorly understood type of childhood brain cancer has a unique molecule signature that may point to which therapies could best fight it.// Armed with targeted molecular treatments, doctors may be able to fight the disease without risking the side effects of prolonged and powerful radiation and chemotherapy at an early age.

The latest research is a collaborative effort looking at a type of childhood tumour known as medulloblastoma, the most common childhood tumour of the CNS. The cancer usually strikes between the ages of 5 and 10. Medulloblastomas are highly malignant, and can spread to the spine and other parts of the body. But over the past few decades, refined treatments have increased survival rates until approximately 80 percent of children survive for five to 10 years after diagnosis.

But the therapies aren't perfect. Radiation and chemotherapy for up to a year at such a young age can lead to hearing loss, cataracts and severe learning disabilities that can leave children unable to live independently in later life.

Led by Dr. Scott Pomeroy, an associate professor of neurology at Children's Hospital in Boston, the researchers found that increased activity of Sonic Hedgehog (SHH), a signaling molecule crucial to brain development, is linked to one type of medulloblastoma. "As compared to chemotherapy, which is non-specific and damages all cells … these very focused treatments will only work on those tumors that have that particular molecular pathway active," says Pomeroy.

Recently developed compounds that can block the uncontrolled SHH signaling found in the tumors could potentially be used as a therapy in children with medulloblastoma. Researchers also found that the clinical outcome of an individual child's struggle with medulloblastoma could be accurately predicted by examining the patterns of gene expression in the cancer at the time of diagnosis.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Inadequate Drug Treatment For Youth
9. FDA Approves New surgery Treatment for Farsightedness
10. Treatment of antibiotics ineffectual in bronchitis
11. Oxygen Treatment may be injurious

Post Your Comments:
(Date:11/8/2009)... UCW Academy of Health holds open ... Victoria, BC (Vocus) November 8, 2009 -- UCW Aca...areer in British Columbia’s health care indu...nesday, November 25, 2009. , ,UCW Academy of Heal...tration, nursing and social services, designs its ...
(Date:11/8/2009)... New book called "Preventing ...by Dr. Roberto Giraldo shows that AIDS is a result...ariety of so-called immune system stressor agents,...al and most of all, emotional. , ...rom Nov. 6 – 8, 2009, cell biologists, physi...
(Date:11/8/2009)...HINGTON, Nov. 7 Today, ...tts, Kaptur, Dahlkemper, Smith, Ellsworth and Lipi...America Act" (H.R. 3962). The amendment maintains ...or abortion and for benefits packages that include...se who receive affordability credits and those who...
(Date:11/8/2009)...lls for Swift Passage of H.R. 3961 to Secure the S...swire-USNewswire/ -- Statement Attributable to: J....ssociation. ,, (Logo: http://www.newscom.com/...ails the passage of the House health reform bill, ...ents and physicians and calls for swift passage of...
(Date:11/8/2009)...LYWOOD, Calif., Nov. 8 ...n of Babies luncheon to recognize prominent indivi...ren and who are role models for March of Dimes com...of the March of Dimes November Prematurity Awarene...were urged to join the fight for preemies! ,, (...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3
... yielded success in controlling certain errors in ...rnative to conventional drugs has won for Prof. He... Hebrew University of Jerusalem, one of this year,... the 71st meeting of the board. , The concept beh...
...o really pan out, expert warns , , THURSDA...ic breast cancer who developed an immune response ...as those who didn,t have an immune response, new r...professor of medicine at the University of Pennsyl...
...ighest standard for contact lens UV protection, S... Lenses for ASTIGMATISM, today became the fourth c... receive the AOA Seal of Acceptance for,Ultraviole...metry,s Meeting(TM), the annual meeting of the Ame...
...ed in One of Canada,s Largest Academic Cancer Cent...ated (Nasdaq: ARAY ), a global leader in the fiel...italier de l,Universite de Montreal (CHUM),has pur...iation oncology centers in Canada, will,utilize th...
...e time is right and the,wording is excellent," sai...Life. "This bill recognizes the God-given Right to...t compromise, it will end the slaughter of,innocen...iary., "Our founding fathers could never have ima...
...e 26 Impliant, Inc., a developer of,novel spine a...announced,that it has resumed European clinical ac... Arthroplasty device designed to treat spinal sten...Sutcliffe, MB ChB, FRCS., (Logo: http://www.news...
Other Medicine News:Health News:RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean 2Health News:RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean 3Health News:Breast Cancer Vaccines Look Promising 2Health News:Breast Cancer Vaccines Look Promising 3Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 2Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 3Health News:First CyberKnife System to be Installed in Canada 2Health News:First CyberKnife System to be Installed in Canada 3Health News:First CyberKnife System to be Installed in Canada 4Health News:Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System 2
(Date:11/6/2009)... , SARASOTA, Fla., Nov. 6 /PRNewswire-FirstCa...y announced that it has signed a definitive agreem...of proprietary medical devices. The Verathon Boar...e closing is subject to customary regulatory appro... approval. The parties expect the closing to be c...
(Date:11/6/2009)... , CHARLESTON, S.C., Nov. 6 /PRNewswire-USN...ll be stopping in South Carolina and Georgia throu...in order to help uninsured and financially-struggl...rovide prescription medicines for free or nearly f...ng 10.2 percent, the Partnership for Prescription ...
(Date:11/6/2009)... , PRINCETON, N.J., Nov. 6 /PRNewswire-FirstC...rd: DSCI), a provider of advanced wound care produ...2009 results before market on Monday, November 16,...t same day to discuss the results at 11:00 am EST....mestic) or (857) 350-1684 (international), with pa...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Pesticides Linked to Blood Disorder 49387 1Pesticides Linked to Blood Disorder 49387 2Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 49384 1Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 49384 2Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 49384 3Aerobically unfit young adults on road to diabetes in middle age 49381 1Aerobically unfit young adults on road to diabetes in middle age 49381 2
... Discuss Results to Be Held at 9:00 A.M. -, EXTON...: VPHM ) first quarter financial results for 2008...0, 2008 before the open of the,U.S. financial mark... live audio webcast at 9:00,a.m. Eastern Time on t...a,management will discuss the 2008 first quarter f...
... 14 Micromet, Inc.,(Nasdaq: MITI ), a biopharmac...bodies for the treatment of cancer, inflammation a...eting of the American Association for,Cancer Resea...mercial,anti-cancer antibodies trastuzumab (Hercep...ristol-Myers Squibb, Imclone, Merck Serono), and,p...
Other Medicine Technology:ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 3Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 4Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 5
BUN (Urea Nitrogen)
Bilirubin Direct Reagent
...e is the first microplate spectrophotometer design...week. With rugged hardware, proven optical perform...arrier of traditional spectrophotometry to obtain ...rument can easily read up to eight, 1 cm Biocell c...
LS 45 Luminescence Spectrometer, 120V
Medicine Products: